Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (591-600 of 692) with videos related to

Pageof 70
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomographyAstrid A M van der Veldt, Mark Lubberink, Henri N Greuter, et al.
Frontiers in Oncology|March 19, 2021
Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving ImmunotherapyStefano Trebeschi, Zuhir Bodalal, Thierry N Boellaard, et al.
Cancer Cell|November 4, 2015
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer DiagnosticsMyron G Best, Nik Sol, Irsan Kooi, et al.
American Journal of Respiratory and Critical Care Medicine|March 28, 2017
Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung CancerPauline L de Goeje, Egbert F Smit, Cynthia Waasdorp, et al.
Cancer Discovery|February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancerElza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
Cell Reports|July 5, 2016
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in PatientsEkaterina A Semenova, Min-Chul Kwon, Kim Monkhorst, et al.
Oncotarget|November 7, 2015
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancerR Jonas A Nilsson, Niki Karachaliou, Jordi Berenguer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2015
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysisJustine L Kuiper, Lizza E Hendriks, Anthonie J van der Wekken, et al.
Journal of Clinical Pathology|August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 yearsA Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
The American Journal of Pathology|July 19, 2011
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcomeDorian R A Swarts, Sandra M H Claessen, Yvonne M H Jonkers, et al.
Pageof 70

Showing results (591-600 of 692) with videos related to

Sort By:
Pageof 70
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomographyAstrid A M van der Veldt, Mark Lubberink, Henri N Greuter, et al.
Frontiers in Oncology|March 19, 2021
Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving ImmunotherapyStefano Trebeschi, Zuhir Bodalal, Thierry N Boellaard, et al.
Cancer Cell|November 4, 2015
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer DiagnosticsMyron G Best, Nik Sol, Irsan Kooi, et al.
American Journal of Respiratory and Critical Care Medicine|March 28, 2017
Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung CancerPauline L de Goeje, Egbert F Smit, Cynthia Waasdorp, et al.
Cancer Discovery|February 19, 2014
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancerElza C de Bruin, Catherine Cowell, Patricia H Warne, et al.
Cell Reports|July 5, 2016
Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in PatientsEkaterina A Semenova, Min-Chul Kwon, Kim Monkhorst, et al.
Oncotarget|November 7, 2015
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancerR Jonas A Nilsson, Niki Karachaliou, Jordi Berenguer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 29, 2015
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysisJustine L Kuiper, Lizza E Hendriks, Anthonie J van der Wekken, et al.
Journal of Clinical Pathology|August 7, 2016
DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 yearsA Jasmijn Hubers, Daniëlle A M Heideman, Sylvia Duin, et al.
The American Journal of Pathology|July 19, 2011
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcomeDorian R A Swarts, Sandra M H Claessen, Yvonne M H Jonkers, et al.
Pageof 70